Gregory Y H Lip. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Anticoagulants/adverse effectsAnticoagulants/standardsAspirin/adverse effectsAspirin/standardsAtrial Fibrillation/epidemiologyAtrial Fibrillation/physiopathologyBlood Coagulation Factors/analysisBrain Ischemia/drug therapyBrain Ischemia/epidemiologyBrain Ischemia/prevention & controlCerebral Hemorrhage/chemically inducedCerebral Hemorrhage/physiopathologyClinical ProtocolsClinical Trials as Topic/statistics & numerical dataComorbidityHumansPatient SelectionPlatelet Aggregation Inhibitors/standardsPlatelet Aggregation Inhibitors/therapeutic usePredictive Value of TestsRisk AssessmentRisk FactorsStroke/drug therapyStroke/epidemiologyStroke/prevention & controlWarfarin/adverse effectsWarfarin/standards
Substances： See more » AnticoagulantsBlood Coagulation FactorsPlatelet Aggregation InhibitorsWarfarinAspirin
Year: 2008 PMID： 18323477 DOI： 10.1161/STROKEAHA.107.506832
Source DB: PubMed Journal: Stroke ISSN： 0039-2499 Impact factor: 7.914